精优药业发布中期业绩 股东应占亏损4.6亿港元 同比盈转亏

Core Points - The company reported a revenue of HKD 28.08 million for the six months ending September 30, 2025, representing a year-on-year decrease of 9.04% [1] - The company experienced a loss attributable to shareholders of HKD 460 million, marking a shift from profit to loss compared to the previous year [1] - The loss per share was HKD 0.1909 [1]